Abpro Corporation
ABP • Biotechnology
$0.52
— 0.00 (0.00%)
Current price
EarningsLatest report: Sep 30, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$2.34B
Growth
-22.2%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.19Negative growth trendWeak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 14, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.52
Change0.00%
Shares Out4.49B
Market Cap$2.34B
Enterprise Value$2.34B
52W Range0.11 - 18.03
Beta-0.00
P/E-245.30
P/FCF-313.96
EV/EBITDA-295.28
EV/FCF-313.28
Earnings Yield-0.41%
Price$0.52
Change0.00%
Shares Out4.49B
Market Cap$2.34B
Enterprise Value$2.34B
52W Range0.11 - 18.03
Beta-0.00
P/E-245.30
P/FCF-313.96
EV/EBITDA-295.28
EV/FCF-313.28
Earnings Yield-0.41%
FCF Yield-0.32%
Dividend Yield0.00%
Gross Margin100.00%
Oper. Margin-54.21%
Profit Margin-39.52%
Debt/Eq-0.21
Current Ratio0.19
Quick Ratio0.19
Revenue 5Y-22.18%
Volume1.33M
Avg Volume1.72M
EPS Surprise0.57
Investment DNA
How strong this company looks for long-term investors
22
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Weak liquidity · 0.19Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-10-20
50/100
Neutral
Bullish
0
Hold
1
Bearish
0
🧾
No insider activity
No recent insider transactions available.